Nestle Health Science US Holdings Inc. 13D and 13G filings for Prometheus Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 10:20 am Purchase | 2021-12-31 | 13G | Prometheus Biosciences, Inc. RXDX | Nestle Health Science US Holdings Inc. | 3,730,841 9.580% | 3,730,841 (New Position) | Filing |